Your browser doesn't support javascript.
loading
Combined thermal ablation and liposomal granulocyte-macrophage colony stimulation factor increases immune cell trafficking in a small animal tumor model.
Moussa, Marwan; Chowdhury, Md Raihan; Mwin, David; Fatih, Mohamed; Selveraj, Gokul; Abdelmonem, Ahmed; Farghaly, Mohamed; Dou, Qianhui; Filipczak, Nina; Levchenko, Tatyana; Torchilin, Vladimir P; Boussiotis, Vassiliki; Goldberg, S Nahum; Ahmed, Muneeb.
Affiliation
  • Moussa M; The Laboratory for Minimally Invasive Tumor Therapies, Department of Radiology, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, Massachusetts, United States of America.
  • Chowdhury MR; The Laboratory for Minimally Invasive Tumor Therapies, Department of Radiology, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, Massachusetts, United States of America.
  • Mwin D; The Laboratory for Minimally Invasive Tumor Therapies, Department of Radiology, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, Massachusetts, United States of America.
  • Fatih M; The Laboratory for Minimally Invasive Tumor Therapies, Department of Radiology, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, Massachusetts, United States of America.
  • Selveraj G; The Laboratory for Minimally Invasive Tumor Therapies, Department of Radiology, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, Massachusetts, United States of America.
  • Abdelmonem A; The Laboratory for Minimally Invasive Tumor Therapies, Department of Radiology, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, Massachusetts, United States of America.
  • Farghaly M; The Laboratory for Minimally Invasive Tumor Therapies, Department of Radiology, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, Massachusetts, United States of America.
  • Dou Q; The Laboratory for Minimally Invasive Tumor Therapies, Department of Radiology, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, Massachusetts, United States of America.
  • Filipczak N; Department of Pharmaceutical Sciences, Northeastern University, Boston, Massachusetts, United States of America.
  • Levchenko T; Department of Pharmaceutical Sciences, Northeastern University, Boston, Massachusetts, United States of America.
  • Torchilin VP; Department of Pharmaceutical Sciences, Northeastern University, Boston, Massachusetts, United States of America.
  • Boussiotis V; Department of Hemotolgy and Oncology, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, Massachusetts, United States of America.
  • Goldberg SN; The Laboratory for Minimally Invasive Tumor Therapies, Department of Radiology, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, Massachusetts, United States of America.
  • Ahmed M; Department of Radiology, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
PLoS One ; 18(10): e0293141, 2023.
Article de En | MEDLINE | ID: mdl-37883367

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Facteur de stimulation des colonies de granulocytes et de macrophages / Tumeurs primitives multiples Limites: Animals Langue: En Journal: PLoS One Sujet du journal: CIENCIA / MEDICINA Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Facteur de stimulation des colonies de granulocytes et de macrophages / Tumeurs primitives multiples Limites: Animals Langue: En Journal: PLoS One Sujet du journal: CIENCIA / MEDICINA Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique